retatrutide trial status Shows 28% Weight Loss in 80 Weeks Retatrutide Delivers Bariatric-Level Weight Loss

Complementary Treatments for Weight Loss We provide a range of other treatments to aid your weight loss journey

No one in the GLP-1 group experienced significant gastrointestinal adverse events during the study, and none discontinued GLP-1 use

No, once you stop taking the injections your bodys metabolism returns to normal, making you susceptible to weight gain

Clinical audit of estradiol implant therapy: long duration of action and implications in non-hysterectomised women

Where did I inject last

FAQ If you are assigned female at birth and experiencing lower abdominal pain that is sudden, intense, and doesnt resolve within a short time, seek immediate medical attention